Page last updated: 2024-08-25

bexarotene and Psychoses

bexarotene has been researched along with Psychoses in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benatov, R; Bush, I; Elliot, H; Gibel, A; Lerner, V; Miodownik, C; Ritsner, MS; Sirota, P	1

Trials

1 trial(s) available for bexarotene and Psychoses

Article	Year
The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12 Topics: Adult; Antipsychotic Agents; Bexarotene; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Retinoid X Receptors; Schizophrenia; Schizophrenic Psychology; Tetrahydronaphthalenes; Treatment Outcome	2013

Article

Year

The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.

The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12

Topics: Adult; Antipsychotic Agents; Bexarotene; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Retinoid X Receptors; Schizophrenia; Schizophrenic Psychology; Tetrahydronaphthalenes; Treatment Outcome

2013